Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Hematopoietic Cell
100%
Cell Transplantation
88%
Hematopoietic Stem Cell Transplantation
53%
Graft-Versus-Host Disease
44%
Infectious Disease
42%
Infection
42%
T Cell
37%
Immune Reconstitution
33%
Cord Blood Stem Cell Transplantation
31%
Allogeneic Hematopoietic Stem Cell Transplantation
26%
Anti-Thymocyte Globulin
20%
Overall Survival
20%
Umbilical Cord Blood
19%
Stem Cell
18%
Lung
18%
Organoid
17%
Myeloid
17%
Acute Graft Versus Host Disease
16%
Adolescence
13%
Engraftment
12%
CD4
12%
Intestinal Stem Cell
11%
Virus
11%
Arm
10%
Steroid
10%
B Cell
10%
Chronic Graft Versus Host Disease
9%
T-Helper Cell
9%
Human Respiratory Syncytial Virus
9%
Immune Response
9%
Event Free Survival
8%
Neutrophil
8%
Rituximab
8%
Autoimmune Disease
8%
Ecalectin
8%
Hematopoiesis
7%
Adenoviridae
7%
Hemophagocytic Lymphohistiocytosis
7%
Cytomegalovirus
7%
Natural Killer Cell
7%
Stem Cell Transplantation
7%
Primary Immunodeficiency
6%
Cell Function
6%
Epithelium
6%
Pharmacokinetics
6%
Morbidity
6%
Coculture
5%
Drug Megadose
5%
Lower Respiratory Tract
5%
Inflammatory Disorder
5%
Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
48%
Hematopoietic Stem Cell Transplantation
26%
Hematopoietic Cell Transplantation
26%
Graft-versus-host Disease (GvHD)
18%
Metachromatic Leukodystrophy
16%
Pediatric
14%
Antithymocyte Globulin
14%
Cord Blood Transplantation
13%
Transplantation
12%
Therapeutic Drug Monitoring
11%
T Cells
10%
Busulfan
9%
Immune Reconstitution
9%
Chronic Graft-versus-host Disease (cGVHD)
9%
Overall Survival
8%
Europe
8%
Galectin-9 (Gal-9)
8%
Pediatric Patients
7%
Invasive Fungal Infection
7%
Eosinophils
7%
Pediatric Transplantation
6%
Risk Factors
6%
T Cell Reconstitution
6%
95% Confidence Interval
6%
Busulfan Exposure
6%
Intestinal Injury
6%
European Reference Networks
6%
Hazard Ratio
6%
Severe Combined Immunodeficiency
6%
Epithelial Regeneration
6%
Intestinal Graft-versus-host Disease
6%
Pediatric Hematopoietic Stem Cell Transplantation
5%
Leukemia
5%
Marrow Transplant
5%
Children with Cancer
5%
T Cell Activation
5%
Graft Failure
5%
Matched Unrelated Donor
5%
Transplant-related Mortality
5%
Respiratory Syncytial Virus
5%
Singles' Day
5%
Adrenoleukodystrophy
5%
Chemotherapy-induced
5%
Vaccine Immunogenicity
5%
Clonal Hematopoiesis
5%
Cytomegalovirus Reactivation
5%
Intestinal Stem Cells
5%
COVID-19
5%
Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
35%
Hematopoietic Cell
31%
Metachromatic Leukodystrophy
26%
Pediatrics
21%
Cell Transplantation
21%
Cord Blood
18%
Diseases
18%
Allogeneic Hematopoietic Stem Cell Transplantation
14%
Cord Blood Stem Cell Transplantation
12%
Pediatrics Patient
11%
Systemic Mycosis
11%
Adolescence
10%
Infection
9%
Thymocyte Antibody
8%
Hematologic Malignancy
6%
Overall Survival
6%
Quality of Life
6%
Acute Lymphoblastic Leukemia
5%
Chronic Graft Versus Host Disease
5%
Leukemia
5%
Cell Therapy
5%
Engraftment
5%
Bloodstream Infection
5%
Adrenoleukodystrophy
5%
Cohort Studies
5%
Conjugate Vaccine
5%
Vaccine Immunogenicity
5%
Hemophagocytic Syndrome
5%
Graft Failure
5%
Area under the Curve
5%
Arm
5%